Clinical trial NCT00055120 - References

HIV Infections — When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Citation(s)

•   Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F
  Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS. 2001 Jul 27;15(11):1369-77.
•   Hamill RJ
  Immune restoration syndrome in AIDS and mycoses. Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; December 16-19, 2001; Chicago, IL. Abtract 1272.
•   Núñez M, Asencio R, Valencia ME, Leal M, González-Lahoz J, Soriano V
  Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2003 May;19(5):363-8.
•   Sax PE, Sloan CE, Schackman BR, Grant PM, Rong J, Zolopa AR, Powderly W, Losina E, Freedberg KA; Cepac US And Actg A5164 Investigators
  Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analys
•   Wislez M, Bergot E, Antoine M, Parrot A, Carette MF, Mayaud C, Cadranel J
  Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2001 Sep 1;164(5):847-51.

A Phase IV Study of Antiretroviral Therapy for HIV Infected Adults Presenting With Acute Opportunistic Infections: Immediate Versus Deferred Initiation of Antiretroviral Therapy

Details for clinical trial NCT00055120